Deals
J&J and Smith & Nephew abandon $34 billion merger over CEO choice
Johnson & Johnson shareholders would have held 50.1% of the combined orthopedics company, with Smith & Nephew raising about $10 billion in debt.
Cevian Capital
Deals
Johnson & Johnson shareholders would have held 50.1% of the combined orthopedics company, with Smith & Nephew raising about $10 billion in debt.